FDA Warning Letter — KM PHARMACEUTICAL CO., LTD.
The FDA took a Warning Letter action against KM PHARMACEUTICAL CO., LTD. on Aug 3, 2023 (Pyeongtaek, South Korea). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- KM PHARMACEUTICAL CO., LTD.
- Date
- Aug 3, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Center
- CDER
- Location
- Pyeongtaek (South Korea)